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Abstract
Background: The widespread problem of antibiotic resistance in pathogens such as Staphylococcus
aureus has prompted the search for new antimicrobial approaches. In this study we report for the
first time the use of a light-activated antimicrobial agent, methylene blue, to kill an epidemic
methicillin-resistant Staphylococcus aureus (EMRSA-16) strain in two mouse wound models.
Results: Following irradiation of wounds with 360 J/cm2 of laser light (670 nm) in the presence of
100 μg/ml of methylene blue, a 25-fold reduction in the number of viable EMRSA was seen. This
was independent of the increase in temperature of the wounds associated with the treatment.
Histological examination of the wounds revealed no difference between the photodynamic therapy
(PDT)-treated wounds and the untreated wounds, all of which showed the same degree of
inflammatory infiltration at 24 hours.
Conclusion: The results of this study demonstrate that PDT is effective at reducing the total
number of viable EMRSA in a wound. This approach has promise as a means of treating wound
infections caused by antibiotic-resistant microbes as well as for the elimination of such organisms
from carriage sites.
Background
The emergence of resistant strains of bacteria such as
methicillin-resistant Staphylococcus aureus (MRSA) poses a
major challenge to healthcare. MRSA is a major cause of
hospital-acquired infection throughout the world and is
now also prevalent in the community as well as nursing
and residential homes [1-3]. Of the Staph. aureus isolates
in the United Kingdom in 2005, 43.6% were found to be
MRSA and a point prevalence survey showed that 16% of
intensive care patients were either colonized or infected
with MRSA [4,5]. Mortality attributable to MRSA bacterae-
mia has been estimated to be 22% [6]. Increasing reports
of resistance to antibiotics and antiseptics, have sparked a
wave of research to find alternative antimicrobial strate-
gies [7,8]. One such strategy involves the use of light-acti-
vated antimicrobial agents (LAAAs) in photodynamic
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light of an appropriate wavelength, singlet oxygen and
free radicals are generated locally which directly attack the
plasma membrane and other cellular targets resulting in
bacteriolysis [10,11]. This could form the basis of an alter-
native approach for the eradication of such bacteria from
superficial wounds, burns, varicose ulcers, pressure sores
and carriage sites which are readily accessible to topical
application of a LAAA and light.
In vitro experiments with PDT have demonstrated effective
bactericidal activity of toluidine blue O (TBO) and meth-
ylene blue (MB) as photosensitisers against MRSA [12-
14]. However, there are few in vivo studies which have
looked at the effect of PDT in wounds, and in particular
ones inoculated with drug-resistant bacteria. Furthermore
there are no reports of the use of PDT in wounds colo-
nised by MRSA. Two mouse studies that investigated the
effect of PDT using a targeted polycationic photosensitiser
demonstrated that PDT is effective at reducing the number
of bacteria in excision wounds infected with Escherichia
coli and Pseudomonas aeruginosa [15,16]. This was also
shown in a burn wound model infected with biolumines-
cent Staphylococcus aureus treated with PDT using a cati-
onic porphyrin [17]. However, within days of treatment,
the bacterial luminescence reappeared, indicating incom-
plete bacterial killing.
A potential problem with PDT however, is its lack of spe-
cificity. Its cytotoxic effect, which destroys bacteria so
effectively, leads to delayed burn-wound healing, presum-
ably as a result of the reactive oxygen species acting on
host tissue [17]. PDT also resulted in delayed healing of
wounds in rat skin grafts [18]. However, treatment of
wounds with laser light alone shows more diverse find-
ings. Delayed wound healing was seen after delivery of
high laser energy (211–420 J/cm2) in burn wounds [17]
in contrast to unchanged or even improved speed of
recovery when lower light energy (upto 75 J/cm2) is used
[18,19].
A further factor associated with red light illumination is
the generation of heat. This is partly due to absorption of
light by endogenous chromophores as well as release of
energy by the excited photosensitiser in the form of heat
rather than the actual PDT effect. As far as we are aware,
no in vivo study has investigated the local heating effect
associated with PDT treatment for microbial eradication
using methylene blue.
The aims of this study were to evaluate the effect of PDT,
using methylene blue as a photosensitiser, on the survival
of an epidemic strain of MRSA in excisional and superfi-
cial wounds in mice. The local heating effect associated
with this PDT treatment was evaluated as well as the
extent of collateral damage to host tissue.
Results
Effect of PDT on the number of viable bacteria in the 
wounds
Figures 1 and 2 show the number of EMRSA-16 isolated
from the treated excision and superficial wounds and their
respective control groups (wounds that did not receive
any treatment, wounds that did not receive MB, and those
that were not irradiated).
Irradiation of the wounds in the presence of MB resulted
in a significant reduction in the number of viable bacteria
recovered from the wounds. This reduction was 25 fold
(1.40 log10 CFU/wound) in the excision wounds and 14
fold (1.15 log10 CFU/wound) in the superficial scarified
wounds.
Effect of PDT on the temperature of the wounds
To study the effects of irradiation on wound temperature,
two groups of animals were examined. One group
Box- and whisker plot of the number of viable MRSA isolated fr m excision wounds treated with photodynamic therapy (PDT)Figure 1
Box- and whisker plot of the number of viable MRSA 
isolated from excision wounds treated with photody-
namic therapy (PDT). The wounds were inoculated with 
EMRSA-16 for one hour, treated with PDT using methylene 
blue and 665 nm laser light (360 J/cm2) and examined imme-
diately after treatment. A 25 fold reduction in the number of 
viable MRSA was seen in the PDT wounds (L+S+) compared 
to the controls. Results are presented as box (median, 25th 
and 75th centiles) and whiskers (minimum and maximum val-
ues), n = 12 per group (* indicates p < 0.008).
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while the other group had full PDT treatment with MB
and laser irradiation (L+S+; n = 3). The wound tempera-
tures at the beginning of treatment were consistently
lower than the core temperatures. The wound temperature
in the animals treated with PDT rose by 13.4 ± 0.5°C and
the maximum temperature achieved in this group was
44.5°C (Figure 3). However, a smaller increase in temper-
ature was noted in wounds irradiated with laser light in
the absence of MB (7.1 ± 2.6°C) with 40.1°C being the
highest temperature reached in this group.
Histological findings following PDT
The cytotoxic effect of PDT on host tissue was examined in
18 biopsies from wounds treated with laser light and MB
in combination. All exhibited a clear demarcation
between wound and the skin and extended into adipose
or loose areolar tissue on their deep aspect. Some
included fragments of the underlying skeletal muscle. In
the area of the wound, the epidermis had been removed
to leave either a thin layer of the underlying connective
tissue overlying the panniculus adiposus, or a wound base
of adipose tissue. In contrast, the adjacent tissue had
retained its epidermis complete with appendages. None
of the wounds examined showed evidence of extensive tis-
sue necrosis.
Normal wound architecture was seen in wounds that were
sampled immediately after PDT (Figure 4A). By 24 hours
there was a heavy lymphocytic infiltrate, which in some
sections extended quite deeply to involve the underlying
muscle. This was very prominent at the wound edges but
less marked towards the centre (Figure 4B). When present
in the latter areas, inflammatory cells could be seen infil-
trating between dermal adipocytes. Wounds examined at
24 hours in the presence of bacteria exhibited a similar
pattern of inflammatory cell infiltration regardless of
whether they were treated with laser light and MB, either
alone or in combination (Figure 4C). Moderate to heavy
bacterial deposits were observed in some wounds and
were generally localised to areas with a heavy fibrin
slough. Observations were made on three biopsies for
each experimental condition.
Discussion
There are many reports in the literature of the ability of
light-activated antimicrobial agents to kill a wide range of
microbes in the laboratory [9,20]. In some of these in vitro
investigations, attempts have been made to model the in
vivo situation by using biofilms of the target organisms
[21] or by carrying out experiments in the presence of
blood or serum.[22,23] In this study we have taken this
further by investigating the ability of a LAAA, methylene
blue, to kill bacteria while present in a wound. Our in vivo
model reflects the early stages of an infectious process i.e.
the initial colonisation of a wound by a potential disease-
inducing organism. We used a strain of MRSA that is
known to cause wound infections with significant clinical
relevance, including fatal outcomes. The results of our
study demonstrate for the first time that it is possible to
reduce the number of viable MRSA present in a wound
using the LAAA methylene blue when activated by 360 J/
cm2 of light (with a wavelength of 665 nm – the absorb-
ance maximum of methylene blue) from a low power
laser.
Although substantial reductions in the viable count of
MRSA in the wounds were achieved, the kills observed in
this in vivo model were substantially lower than those
reported in in vitro studies. Hence, using light doses as low
as 43 J/cm2, 4.7 log10 reductions in the viable count of a
suspension of MRSA (1010 CFU/ml) were obtained using
the LAAA toluidine blue O (a phenothiazinium dye
closely related to methylene blue) at a concentration of
12.5 μg/ml [12]. Wainwright et al. also reported that
methylene blue and toluidine blue O are extremely effec-
tive LAAAs against MRSA in vitro [13]. To our knowledge,
only three papers have been published on the use of
LAAAs to kill S. aureus in vivo [17,24,25]. Each of these has
used a different animal model and a different LAAA which
makes comparisons with the present study difficult. How-
ever, in all of these studies the bacterial kills reported were
Box- and whisker plot of the number of viable MRSA isolated fr m superficial scarified wounds following photodynamic therapyFigure 2
Box- and whisker plot of the number of viable MRSA 
isolated from superficial scarified wounds following 
photodynamic therapy. The wounds were examined 
immediately after treatment. A 14-fold reduction in the 
number of viable bacteria was observed in the PDT treated 
wounds (L+S+) compared to the control wounds. (* indi-
cates p = 0.002).
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vitro. For example, when the LAAA meso-mono-phenyl-
tri(N-methyl-4-pyridyl)-porphyrin (PTMPP) was used to
kill S. aureus in burn wounds in mice, the kills achieved
amounted to less than 2 log10 units using a light dose of
211 J/cm2 [17]. Much greater kills were attained in vitro
using a considerably lower light dose (0.6 J/cm2 compared
with 211 J/cm2) and concentration of PTMPP (1.6 μM in
vitro compared with 500 μM in vivo). Several factors may
account for the reduced bactericidal effect observed in vivo
including: (i) binding of the LAAA to host material
thereby reducing the effective dose and resulting in the
generation of singlet oxygen in regions remote from the
target bacteria, (ii) absorption of laser light by LAAA
bound to host tissues – this would result in shielding of
any LAAA bound to bacteria preventing light activation
and (iii) quenching of singlet oxygen by host molecules
thereby protecting bacteria from its harmful effects. Some
of these problems could be avoided, and hence greater
kills achieved in vivo, by using a photosensitiser covalently
linked to a bacterial targeting moiety [15,24].
One aspect of the in vivo use of antimicrobial PDT that has
not previously been investigated is the change in temper-
ature of the host tissues accompanying the procedure.
Treatment of basal cell carcinoma with 5-aminolevulinic
acid and red light (590–700 nm) with a power density of
100 mW/cm2 resulted in a 8–10°C change in the surface
temperature of the lesion [26]. In our study we found that
irradiation with 360 J/cm2 of light in the presence of
methylene blue resulted in a substantial rise in the wound
temperature – the average maximum temperature at the
centre of the wounds being 42.7 ± 1.8°C. However, it is
very unlikely that such a temperature increase could
Effect of laser light alone and laser light with methylene blue on wound temperatureFigure 3
Effect of laser light alone and laser light with methylene blue on wound temperature. Temperature was measured 
using a thermistor tunnelled into the centre of the wounds. There was an immediate increase in the temperature of the 
wounds following the start of irradiation with laser light of 665 nm wavelength and power rating of 200 mW/cm2. There was a 
bigger increase in temperature in the PDT treated wounds (black squares) than in the light only (grey triangles) treated group. 
The temperature dropped upon cessation of irradiation.
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to grow at temperatures as high as 45°C [27]. Further-
more, the decimal reduction time for the organism at a
higher temperature of 50°C is of the order of 105 minutes
whereas in the current study, the wound temperature was
above 40°C for no longer than 10 minutes and did not
reach 45°C [28].
Microscopic examination of biopsies immediately follow-
ing treatment and after 24 hours did not reveal any tissue
necrosis regardless of the experimental treatment applied.
Thus, at the 24 hour time point the use of PDT did not
amplify the effect of the wounding.
This study has demonstrated that substantial kills of
MRSA can be achieved in an in vivo mouse wound model
using the LAAA methylene blue, and without causing col-
lateral damage to host tissues. These findings are signifi-
cant for several reasons. They constitute the first report of
the in vivo killing of MRSA using LAAAs. Secondly, they
support the small, but growing, number of in vivo studies
demonstrating that PDT is an effective antimicrobial.
Thirdly, if such results can be reproduced in humans, the
technique could be an effective means of preventing the
colonisation of wounds by the organism and, possibly be
used to eliminate MRSA from carriage sites such as the
anterior nares. It should be noted that only a single appli-
cation of PDT was used in this study and greater kills may
be achieved through repeated application of the tech-
nique or by the "fractionation" of the light dose adminis-
tered or in combination with other therapeutic agents
such as antibiotics. We are currently investigating such
modifications of the technique.
In this era of concern over the threat of the growing anti-
biotic resistance of pathogens such as MRSA to antibiotics,
PDT offers an important advantage in that it is unlikely
that the organism could develop resistance to this modal-
ity[11,14]. Another advantage of PDT is that, unlike the
vast majority of antibiotics, it can also inactivate micro-
bial virulence factors in addition to its microbicidal effect.
Hence, the biological activities of the proteases of Pseu-
domonas aeruginosa and Porphyromonas gingivalis and the
lipopolysaccharide of Escherichia coli have all been shown
to be reduced by irradiation in the presence of a LAAA
[29,30]. The future of LAAAs for the prevention and/or
treatment of infectious diseases looks promising follow-
ing the recent report of the use of methylene blue to suc-
cessfully treat periodontitis – one of the most prevalent
infectious diseases of humans.[31]
Conclusion
In this study we have shown that PDT using the light-acti-
vated antimicrobial agent, methylene blue, kills MRSA in
superficial and deep excisional wounds in mice. However,
killing is less effective than when performed in-vitro. This
bactericidal effect was not due to the heat generated as a
consequence of the treatment. Histological examination
of the wounds showed neither collateral tissue necrosis
nor architectural disturbance.
Methods
Bacteria
The organism used in this investigation was the prototypic
UK epidemic MRSA: EMRSA-16 (NCTC 13143). EMRSA-
16 was maintained by weekly sub-culture on blood agar
(BA, Oxoid Ltd, Basingstoke, UK) supplemented with 5%
Haematoxylin & Eosin stained sections of treated and control woundsFigure 4
Haematoxylin & Eosin stained sections of treated and control wounds. (A) Normal tissue architecture is seen in 
wounds taken immediately after treatment with photodynamic therapy. (B) At 24 hours, a dense cellular infiltrate appears at 
the wound edges inoculated with MRSA and treated with methylene blue only (L-S+). There are also smaller, focal lymphocytic 
aggregates infiltrating between subcutaneous adipocytes in the wound crater. (C) Following photodynamic therapy with laser 
light and methylene blue (L+S+), the wounds show a dense cellular infiltrate at the edges and the subcutaneous fat very similar 
to the control wounds.
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nies were inoculated into brain heart infusion broth (BA,
Oxoid Ltd, Basingstoke, UK) and grown aerobically with
shaking for 16 hours at 37°C. Cells were then harvested
by centrifugation, washed and resuspended in sterile
phosphate buffered saline (PBS) to a concentration of 4 ×
109 bacteria per ml. Twenty five μl of the bacterial suspen-
sion (108 CFU of EMRSA-16) was then added to the
wound.
Photosensitiser and laser
Methylene blue (MB, Sigma, UK) solution was prepared
fresh for each experiment in sterile PBS to a final concen-
tration of 100 μg/ml. The light source used was a 665 nm
diode laser (PerioWave system, Ondine Biopharma, Van-
couver, Canada) with a measured output of 200 mW dis-
tributed by a fibreoptic cable and a diffusing head. The
source was held at a constant distance from the wound to
produce a 1 cm2 circle of illumination.
Animals
All animal experiments were carried out in accordance
with the Animals (Scientific Procedures) Act 1986 and
with approval of the local Ethics Committee. Eight-week
old female C57 Black mice (Charles River, Margate, Kent,
UK), of 14–18 g body weight were housed in the local ani-
mal unit for 7 days prior to experimentation, with free
access to food and water.
Excisional wound model
Mice were anaesthetised with an intramuscular injection
of ketamine-xylazine mixture (90 mg/kg ketamine, 9 mg/
kg xylazine), and their backs shaved and depilated with a
commercial cream (Veet®, Reckitt Benckiser, UK). Intra-
muscular Carpofen (5 mg/kg) was used to provide analge-
sia. At 45 minutes post-inoculation, the mice received a
second dose of the anaesthetic mixture to allow for the
subsequent treatment. The skin was washed with 70% (v/
v) ethanol and left to dry prior to wound creation. Exci-
sion wounds were created by pinching and lifting the skin
of the back using sterile forceps and cutting a 6 mm circu-
lar (28 mm2) area using sharp scissors to cut down to the
subcutaneous areolar tissue. Twenty-five μl of the bacte-
rial suspension was then added to the wound (108 CFU of
EMRSA-16), and incubated for one hour prior to treat-
ment. MRSA was found to be the predominant bacterium
colonising the wound at day 5 (data not included).
Superficial wound model
The preparation of the animals for this model was as
described for the excisional wound model above. 25 mm2
square shaped wounds were created in the skin of the back
by scarification using a 27G needle, run ten times parallel
in one direction and another ten times perpendicular to
the original tracks. The wounds were visibly red and
mildly swollen after 30 minutes. Ten μl of the bacterial
suspension was placed on the wound (4 × 107 CFU of
EMRSA-16), and incubated for one hour prior to treat-
ment. This method also resulted in a reproducible MRSA
wound colonisation model, which persisted for up to 5
days post inoculation (data not shown).
Photodynamic therapy (PDT)
All experiments were carried out under subdued room
lighting. PDT was performed 1 hour after inoculating the
wounds with the bacterial suspension. The excision
wounds received 25 μl of MB (100 μg/ml) solely at the
start of irradiation, whilst the superficial scarified wounds
received 10 μl of MB just before the start of irradiation and
a further 10 μl after 15 minutes of irradiation. The wounds
were irradiated immediately after the application of MB
and continued for 30 minutes. This equated to a total
delivered light dose of 360 J/cm2. Following the comple-
tion of treatment, a circular area of skin and associated
subcutaneous tissue of 1 cm diameter with the wound at
its centre, was removed using sterile scissors. These were
then placed in 0·5 ml Stuart's transport medium and
shielded from light until delivery to the microbiology lab-
oratory for processing and analysis within 2 hours. The
animals were subsequently culled in accordance with the
Animal Scientific Procedures act (1986).
Control groups were used to test the effect of MB alone
(by incubating wounds in the dark for the equivalent time
period as needed for irradiation, L-S+, where L denotes
light treatment and S denotes photosensitiser), light alone
(by illuminating wounds in the absence of MB, L+S-). A
final untreated control group received no MB or light illu-
mination (L-S-). PBS was used instead of MB in the con-
trol wounds that received no MB.
Twelve mice per group were examined in the excision
wound model, whereas 6 mice per group were used in the
superficial scarified wound model.
In preliminary experiments, the dose of MB (concentra-
tion and volume of solution) was optimised to achieve
maximum bacterial kill. For the excision wounds, 25 μl of
MB at a concentration of 100 μg/ml was most effective.
However, for the superficial scarified wounds, the same
concentration of MB was used but in a reduced volume of
10 μl administered at two separate time-points, 15 min-
utes apart. The delivered light dose which produced the
greatest bacterial kill in both types of wounds was opti-
mised to 360 J/cm2, although light doses of 180 J/cm2 also
reduced the number of viable bacteria recovered.
Processing of tissue samples
Using a micro-Eppendorf pestle, the tissue in Stuart's
transport medium was minced to release the bacteriaPage 6 of 8
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kept in the dark during processing. The contents of the
Eppendorf tube were transferred into 4.5 ml of PBS. Aliq-
uots of serial 10-fold dilutions of the suspension were
plated onto half plates of BA and mannitol salt agar
(MSA). Plates were incubated at 37°C in air for 36 hours
before colonies of EMRSA-16 were counted. Results repre-
sent the mean CFU of EMRSA-16 recovered per wound
based on counts from both BA and MSA plates for each
sample.
Histological evaluation
For these studies, wounds were removed either immedi-
ately or after 24 hours following treatment and fixed in
4% formal saline for 24 hours. The specimens were proc-
essed and embedded in paraffin wax. 6 μm histological
sections were cut stained with haematoxylin-eosin and
examined by light microscopy.
Wound temperature studies
Following creation and inoculation of the excision
wounds with bacteria for 1 hour, a 1 mm diameter ther-
mistor (Thermilinear® component, Yellow Spring Instru-
ments Co., Ohio, USA) was tunnelled subcutaneously
from an entry point 2 cm away from the wound to its cen-
tre, avoiding disruption of the wound integrity. PDT was
then performed as above and temperature changes plot-
ted. A single control group had wounds irradiated with
laser light in the absence of MB (L+S-).
Statistical analysis
Data are expressed as mean ± standard error or median
(95% confidence intervals). Group comparison for con-
tinuous variables was tested with the t-test (for tempera-
ture changes) and Mann Whitney U test for the rest of the
data. Multiple comparisons increase the risk of type I
errors. In order to prevent such errors, we used the Bonfer-
roni method and divided the 5% alpha level by the
number of comparisons. Hence, when pair-wise compari-
sons were performed between treatment groups, p was
only significant if it was < 0.008. All tests were performed
with the use of SPSS 14.0 for Windows.
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